Cover Story: MassNextGen Entrepreneur in MedTech Outlook

Congratulations to Roya Khosravi-Far, Co-Founder and CEO of InnoTech Precision Medicine, who was featured as the cover story in MedTech Outlook. The article highlighted the company’s efforts to democratize early cancer detection. According to the latest research, approximately 50 percent of cancers are still only detected at an advanced stage. Roya and her team are working to make advanced cancer diagnostics accessible to all.

InnoTech Precision Medicine is developing a pioneering biosensor platform technology for the next generation of point of care diagnostics. The MLSC is proud to have the company as part of its 4th cohort of the Massachusetts Next Generation (MassNextGen) Initiative. Awardees of the program receive a year-long customized package of support, which includes non-dilutive grant funding and access to a network of seasoned professionals from the life sciences ecosystem helping them to refine their business strategies and effectively raise capital.

Share This Post

Featured in The Beat
MLSC Brandmark scaled 1